NCT06349668 2026-02-05
SMILe
University Hospital, Linkoeping
Phase 3 Recruiting
Clinical Trials
16 trialsNCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
NCT03823534 2025-10-15
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
St. Louis University
Phase 3 Recruiting
NCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
NCT03825887 2021-08-02
PCA
Children's Cancer Hospital Egypt 57357
Phase 3 Completed
NCT00003687 2020-04-03
Treatment for Chronic Pain in Patients With Advanced Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
NCT02591017 2018-11-13
ONKEMI
University Hospital, Basel, Switzerland
Phase 3 Terminated
NCT01675622 2018-05-21
Immediate-Release Oxycodone Capsules Study in Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT02687347 2016-09-20
UDOME
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 3 Unknown
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00201539 2015-04-08
Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients
Norwegian University of Science and Technology
Phase 3 Completed
NCT01309386 2013-03-13
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants
Janssen Pharmaceutical K.K.
Phase 3 Completed
NCT01367418 2012-03-19
AIMS
Örebro University, Sweden
Phase 3 Completed
NCT00410540 2010-04-27
A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
Alza Corporation, DE, USA
Phase 3 Completed
NCT00822614 2009-01-14
FINDS
Akela Pharma, Inc.
Phase 3 Unknown